Patents by Inventor Russell K. Pachynski

Russell K. Pachynski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9868792
    Abstract: Chemerin is a chemoattractant that selectively directs intra-tumor recruitment of CMKLR1+ cells. Blockade of CCRL2 from binding to chemerin in non-neoplastic tumor cells, e.g. peri-tumor stromal and/or hematopoietic cells allows for redistribution of chemerin into the tumor and enhanced responsiveness against a tumor.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: January 16, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Brian A. Zabel, Eugene C. Butcher, Russell K. Pachynski, Justin Monnier
  • Publication number: 20170002087
    Abstract: Chemerin is a chemoattractant that selectively directs intra-tumor recruitment of CMKLR1+ cells. Blockade of CCRL2 from binding to chemerin in non-neoplastic tumor cells, e.g. peri-tumor stromal and/or hematopoietic cells allows for redistribution of chemerin into the tumor and enhanced responsiveness against a tumor.
    Type: Application
    Filed: June 30, 2016
    Publication date: January 5, 2017
    Inventors: Brian A. Zabel, Eugene C. Butcher, Russell K. Pachynski, Justin Monnier
  • Publication number: 20160032398
    Abstract: The disclosure features a method of treating cancer by lowering a patient's two gene score (TGS), particularly by increasing the number of tumor-infiltrating leukocytes. In addition, a TGS animal model and uses thereof are provided.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 4, 2016
    Inventors: Russell K. Pachynski, Holbrook E. Kohrt, Jason Yonehiro